Karolinska Development has repaid the remaining part of the company's convertible loanHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechHomeMailNewsFinanceSportsEntertainmentSearchMobileMore...YAHOO_FINANCESearchSign inMailSign in to view your mailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Karolinska Development has repaid the remaining part of the company's convertible loanGlobeNewswireJanuary 9, 2020ReblogShareTweetShareSTOCKHOLM – January 9, 2020. Karolinska Development (Nasdaq Stockholm: KDEV) announces that the company has made the final repayments on the convertible loan issued in 2015.The convertible loan with a nominal amount of SEK 387 million was issued by Karolinska Development in January 2015 and which was due for payment on December 31, 2019. During 2019 the company carried out a directed share issue to the holders of the convertible loan where the loan, including accrued interest until December 31, 2019, was set off against shares. At the end of the subscription period, 19.7 million of the convertible loan was outstanding, including accrued interest until December 31, 2019. This amount has now been repaid to the holders of the convertible loan and with that, the whole convertible loan is resolved.“An intensive work on solving the convertible loan has now come to an end. At the end of last year, we also announced that our short-term financing needs have been secured through a loan amounting to SEK 70 million. We now look forward to an eventful year focusing on the development in our portfolio companies, where Aprea, Umecrine Cognition and Dilafor are next in line to present important clinical research results. We will also initiate the cooperation with Sino Biopharmaceutical for the purpose of opening the Asian market for Nordic innovations”, comments Karolinska Development’s CEO, Viktor Drvota.     For further information, please contact: Viktor Drvota, CEO, Karolinska Development AB Phone: +46 73 982 52 02, e-mail: viktor.drvota@karolinskadevelopment.comTO THE EDITORSAbout Karolinska Development AB Karolinska Development AB (Nasdaq Stockholm: KDEV) is a Nordic life sciences investment company. The company focuses on identifying breakthrough medical innovations in the Nordic region that are developed by entrepreneurs and leadership teams. The Company invests in the creation and growth of companies that advance these assets into commercial products that are designed to make a difference to patients' lives while providing an attractive return on investment to shareholders.Karolinska Development has access to world-class medical innovations at the Karolinska Institutet and other leading universities and research institutes in the Nordic region. The Company aims to build companies around scientists who are leaders in their fields, supported by experienced management teams and advisers, and co-funded by specialist international investors, to provide the greatest chance of success.Karolinska Development has established a portfolio of ten companies targeting opportunities in innovative treatment for life-threatening or serious debilitating diseases.The Company is led by an entrepreneurial team of investment professionals with a proven track record as company builders and with access to a strong global network.For more information, please visit www.karolinskadevelopment.comAttachment Karolinska Development repayment convertible 200109 ReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextIt’s Not Just You, Seed Rounds Are Actually Getting BiggerCrunchbaseBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance Video'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceDon’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoMost face masks won’t protect you from the coronavirusYahoo FinanceStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceStock Market Live Updates: Stocks stretch to new records; United Steel plunges on layoffs, profit warningYahoo FinanceBeyond Meat beats on Q4 earnings, founder says 'we would be crazy not to invest in growth right now'Yahoo FinanceWhat to watch in the markets: Friday, February 28Yahoo Finance Video